EXAS vs MAR · rev $2.76B vs P/E 32, rev $26.19B
EXACT Sciences Corporation (EXAS) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
EXAS currently screens at market cap $20.03B. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the EXAS and MAR stock pages for the full models.
Not investment advice.